Odysseas Kostas D 4
4 · Armata Pharmaceuticals, Inc. · Filed Feb 7, 2025
Insider Transaction Report
Form 4
Kostas Odysseas D
Director
Transactions
- Award
Stock Options (Right to Buy)
2025-02-05+54,343→ 54,343 totalExercise: $2.04Exp: 2035-02-05→ Common Stock (54,343 underlying)
Footnotes (1)
- [F1]The Options shall vest (i) 50% on February 5, 2026 and (ii) 50% on February 5, 2027, in each case subject to continuous service through such vesting date.